There are over 400 different types of dementia, and Penn Medicine is at the forefront of seminal discoveries that have uncovered the causes dementia in its various forms. Led by Edward Lee, MD, PhD, Penn Medicine scientists study rare forms of dementia such as vacuolar tauopathy, an early onset form of frontotemporal degeneration for which there is no treatment or cure.  Dr. Lee and his lab are currently developing and testing drug like compounds in pre-clinical experimental models that target VCP with the goal of developing novel therapies for rare diseases like vacuolar tauopathy and common diseases such as Alzheimer's disease.


Your support will help accelerate the efforts to develop disease-modifying therapies and to improve the quality of life for those suffering from these devastating disorders. Your online donation can be made here.